TAILIEUCHUNG - DEHYDROGENASES

The book takes in consideration some dehydrogenases, enzymes with different functions in the cells by using different substrates, such as hydroxysteroid dehydrogenases, aldehyde dehydrogenases, glucose-6-phosphate dehydrogenase, pyruvate dehydrogenase complex, glutamate dehydrogenase, succinate dehydrogenase. They are examined from the following points of view: biochemistry, physiological functions and role in some diseases and in the development of tumours. For these reasons, the book is divided into three sections: 1. Dehydrogenases and cancer 2. Dehydrogenases and some diseases 3. Dehydrogenases and physiological role. | DEHYDROGENASES Edited by Rosa Angela Canuto Dehydrogenases http 2903 Edited by Rosa Angela Canuto Contributors Adil M. Allahverdiyev Malahat Bagirova Olga Nehir Oztel Serkan Yaman Emrah Sefik Abamor Rabia Cakir Koc Sezen Canim Ates Serhat Elcicek Serap Yesilkir Baydar Ellen Friday Robert Oliver III Francesco Turturro Tomas Welbourne Paul M. Bingham Zuzana Zachar P. Naik S. Prasad L. Cucullo Nina Atanassova Yvetta Koeva Nwaoguikpe Reginald Nwazue Agnieszka Wolinska Zofia Stgpniewska Dorota Kregiel Marie Kondrashova Marina Zakharchenko Andrej Zakharchenko Natalya Khunderyakova Eugen Maevsky Matgorzata Kotula-Balak Anna Hejmej Barbara Bilinska Ines Canosa Fernando Govantes Marco Cardosi Zuifang Liu Published by InTech Janeza Trdine 9 51000 Rijeka Croatia Copyright 2012 InTech All chapters are Open Access distributed under the Creative Commons Attribution license which allows users to download copy and build upon published articles even for commercial purposes as long as the author and publisher are properly credited which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech authors have the right to republish it in whole or part in any publication of which they are the author and to make other personal use of the work. Any republication referencing or personal use of the work must explicitly identify the original source. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials instructions methods or ideas contained in the book. Publishing Process Manager Oliver Kurelic Typesetting InTech Prepress Novi Sad Cover InTech Design Team First published .

• Sinh học
• Cancer Chemotherapy
• Dehydrogenase Complex
• Barrier Pathophysioloy
• Soil Environment
• Glutamate Dehydrogenases
• Physiological Role
• BMC Cancer
• Advanced breast cancer
• Adjuvant chemotherapy
• Primary systemic chemotherapy
• Postoperative chemotherapy
• Neoadjuvant chemotherapy
• Esophageal cancer
• Despite advances
• Gastric cancer
• Palliative chemotherapy
• Combination chemotherapy
• Advanced gastric cancer
• Triplet chemotherapy
• Doublet chemotherapy
• Meta analysis
• First line chemotherapy
• Perioperative chemotherapy
• Overall survival
• Lung cancer
• Patient preferences
• Chemotherapy treatment options
• Non small cell lung cancer
• Peritoneal metastasis
• Intraperitoneal chemotherapy
• Pressurized intraperitoneal aerosol chemotherapy
• Palliative treatment
• Systemic chemotherapy
• Primary debulking surgery
• Primary peritoneal cancer
• Visible tumours despite
• Ovarian cancer
• Germline BRCA
• Chemotherapy response scores
• Metastatic setting
• Positron emission tomography
• Chemotherapy induced neutropenia
• Clinical study
• Breast Cancer
• Therapeutic equivalence
• Risk factor
• Multimodal treatment strategies
• Lymph node dissection
• FAC chemotherapy
• AC chemotherapy
• Disease free survival
• Adjuvant leukoprotective
• Metronomic chemotherapy
• Low dose chemotherapy
• Head neck cancer
• Personalized medicine
• Acute toxicities
• Head and neck cancer
• Dose dense chemotherapy
• Induction chemotherapy
• 5 fluorouracil plus docetaxel
• Preoperative chemoradiotherapy
• Adjuvant therapy
• Pancreatic cancer
• Second line chemotherapy
• Gemcitabine chemotherapy
• Therapeutics strategy
• Early breast cancer
• Quality of life
• Chemotherapy induced nausea
• Including homeopathy
• Locally advanced breast cancer
• Pathologic complete response
• Lymph node
• Tumor infiltrating lymphocytes
• Cervical cancer
• Survival outcomes
• Chemotherapy plus bevacizumab
• Chemotherapy alone
• Postmenopausal women
• Colorectal cancer
• Chemotherapy induced nausea and vomiting
• Moderate emetic risk
• Female patients
• Pegylated liposomal doxorubicin
• Conventional anthracycline
• Concurrent chemotherapy
• Triple negative breast cancer
• Doxorubicin based chemotherapy
• Residual cancer burden
• Predictive marker